Now showing items 1-3 of 3

  • Ethnic disparities in breast cancer survival in New Zealand: which factors contribute?

    Tin Tin, Sandar; Elwood, J. Mark; Brown, Charis; Sarfati, Diana; Campbell, Ian; Scott, Nina; Ramsaroop, Reena; Seneviratne, Sanjeewa; Harvey, Vernon; Lawrenson, Ross (BioMed central, 2018)
    Background: New Zealand has major ethnic disparities in breast cancer survival with Maori (indigenous people) and Pacific women (immigrants or descended from immigrants from Pacific Islands) faring much worse than other ...
  • Treatment and survival disparities by ethnicity in New Zealand women with stage I-III breast cancer tumour subtypes

    Lawrenson, Ross; Lao, Chunhuan; Campbell, Ian; Harvey, Vernon; Seneviratne, Sanjeewa; Edwards, Melissa; Elwood, Mark; Scott, Nina; Kidd, Jacquie; Sarfati, Diana; Kuper-Hommel, Marion (Springer, 2017)
    Purpose This study aims to look at the distribution of different subtypes of stage I–III breast cancer in Māori and Pacific versus non-Māori/Pacific women, and to examine cancer outcomes by ethnicity within these different ...
  • The use of trastuzumab in New Zealand women with breast cancer

    Lawrenson, Ross; Lao, Chunhuan; Campbell, Ian; Harvey, Vernon; Brown, Charis; Seneviratne, Sanjeewa; Edwards, Melissa; Elwood, Mark; Kuper-Hommel, Marion (Wiley, 2017)
    Aim Trastuzumab was first funded in New Zealand for use in HER2+ve stage I–III breast cancer in 2007. This observational study aims to ascertain the patterns of use of trastuzumab in women with invasive HER2+ve breast ...